DE:8CC / Cocrystal Pharma, Inc. - Institusjonelt eierskap - Kjøpere

Cocrystal Pharma, Inc.
DE ˙ DB ˙ US19188J4094
€ 1,24 ↓ −0,01 (−0,80%)
2025-09-09
AKSJEKURSEN
Institusjonelt- og fondseierskap - Kjøpere

De største eierne som har åpnet nye posisjoner i Cocrystal Pharma, Inc. inkluderer Raymond James Financial Inc .

Denne siden viser endringer i eierstrukturen ved å liste opp institusjoner, fond og større aksjonærer som har økt sine eierandeler eller åpnet nye posisjoner i løpet av den siste rapporteringsperioden. Grønne rader indikerer nye posisjoner. Klikk på lenkeikonet for å se hele transaksjonshistorikken.

Oppgraderfor å låse opp premiumdata.

Fildato Kilde Investor Type Gjennomsnittlig pris
(estimert)		 Aksjer Δ Aksjer
(%)		 Rapportert verdi ($1000) Verdi (%) Portallokering (%)
2025-08-15 13F Tower Research Capital LLC (TRC) 3 663 87,17 5 150,00
2025-07-24 NP FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 39 403 6,46 68 4,69
2025-08-14 13F Raymond James Financial Inc 215 0
2025-08-14 13F Susquehanna International Group, Llp 40 619 20,59 61 27,66
2025-08-14 13F Wells Fargo & Company/mn 1 812 30 100,00 3
2025-08-14 13F Bank Of America Corp /de/ 9 101 0,88 14 8,33
2025-07-24 NP FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 9 629 11,10 17 14,29
2025-08-14 13F UBS Group AG 21 915 30,40 33 39,13
2025-08-12 13F Proequities, Inc. 0 0
Other Listings
US:COCP USD 1,45
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Top Investors
Features
Explore
Help Center